| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.98T | 1.84T | 1.73T | 1.66T | 1.58T |
| Gross Profit | 347.05B | 315.86B | 284.78B | 258.45B | 260.14B |
| EBITDA | 155.92B | 149.00B | 128.99B | 119.68B | 120.72B |
| Net Income | 99.03B | 93.86B | 74.69B | 70.36B | 69.58B |
Balance Sheet | |||||
| Total Assets | 1.37T | 1.22T | 1.08T | 1.06T | 1.01T |
| Cash, Cash Equivalents and Short-Term Investments | 276.33B | 238.90B | 249.56B | 271.13B | 262.24B |
| Total Debt | 234.17B | 124.47B | 80.02B | 91.87B | 95.28B |
| Total Liabilities | 870.90B | 755.35B | 674.27B | 656.98B | 640.09B |
| Stockholders Equity | 496.35B | 466.44B | 402.67B | 401.53B | 361.78B |
Cash Flow | |||||
| Free Cash Flow | 16.71B | 68.16B | 76.30B | 59.39B | 101.09B |
| Operating Cash Flow | 40.37B | 85.61B | 90.88B | 82.10B | 112.48B |
| Investing Cash Flow | -41.70B | -46.51B | -13.11B | -58.09B | -20.51B |
| Financing Cash Flow | 37.22B | -45.84B | -96.79B | -40.06B | -34.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥1.01T | 8.70 | 19.60% | 1.94% | 3.42% | 30.95% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | ¥1.09T | 10.53 | 19.43% | 5.16% | 7.73% | 4.60% | |
61 Neutral | ¥948.78B | 9.73 | 11.06% | 2.88% | 8.32% | 24.62% | |
58 Neutral | ¥154.24B | 14.03 | 8.95% | 3.39% | 20.87% | 16.79% | |
56 Neutral | ¥4.85T | 22.13 | 7.67% | 1.18% | 10.53% | 20.50% | |
54 Neutral | ¥4.20T | 14.95 | 10.15% | 1.86% | 3.21% | 13.04% |